References
- Ayton D, Ayton S, Barker AL, Bush AI, Warren N. (2019) Parkinson’s disease prevalence and the association with rurality and agricultural determinants. Parkinsonism Relat Disord. 61:198-202
- Beauchamp L, Finkelstein D, Bush A, Evans A, Barnham K. (2020) Parkinsonism as a Third Wave of the COVID-19 Pandemic? Journal of Parkinson’s Disease, 10(4) 1343-1353
- Bhidayasiri R, Panyakaew P, Trenkwalder C, Jeon B, Hattori N, Jagota P, Wu Y, Moro E, Lim S, Shang H, Rosales R, Lee J, Thit W, Tan E, Lim T, Tran N, Binh N, Phoumindr A, Boonmongkol T, Phokaewvarangkul O, Thongchuam Y, Vorachit S, Plengsri R, Chokpatcharavate M, Fernandez H. (2020) Delivering patient-centered care in Parkinson’s disease: Challenges and consensus from an international panel. Parkinsonism and Related Disorders, 72;82-87
- Eldeeb A, Hussain F and Siddiqi Z. (2020) COVID 19 infection may increase the risk of parkinsonism – Remember the Spanish flu? Cytokine & Growth Factor Reviews, 54;6-7
- Deloitte, A. (2015). Living With Parkinson’s Disease–An Updated Economic Analysis 2014. In: Parkinson’s Australia Inc., Deloitte Access Economics Canberra.
- MacMahon, D. G., & Thomas, S. (1998). Practical approach to quality of life in Parkinson’s disease: The nurse’s role. Journal of Neurology, Supplement, 245(1), S19-S22. doi:http://dx.doi.org/10.1007/pl00007732
- Rossiter, R., Bramble, M., Matheson, A., Carroll, V., & Phillips, R. (2019). Evaluating the impact of two Specialist Parkinson’s disease nurse positions in regional New South Wales, Australia: A qualitative descriptive study.
- Williams, D. R., Evans, A. H., Fung, V. S. C., Hayes, M., Iansek, R., Kimber, T., . . . Sue, C. M. (2017). Practical approaches to commencing device-assisted therapies for Parkinson disease in Australia. Internal Medicine Journal, 47(10), 1107-1113. doi:http://dx.doi.org/10.1111/imj.13398
- Lim S, Tan A, Fox S, Evans A, Low S, (2017) Integrating patient concerns into Parkinson’s disease management, Curr. Neurol. Neurosci. Rep. 17 3.